Reply: Regulatory T cells-an important target for cancer immunotherapy
Nat Rev Clin Oncol
.
2014 Jun;11(6):307.
doi: 10.1038/nrclinonc.2013.208-c2.
Epub 2014 Apr 29.
Authors
Charles G Drake
1
,
Evan J Lipson
1
,
Julie R Brahmer
1
Affiliation
1
Department of Oncology, Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231, USA.
PMID:
24781414
PMCID:
PMC4732695
DOI:
10.1038/nrclinonc.2013.208-c2
No abstract available
Publication types
Letter
Comment
MeSH terms
Cancer Vaccines / therapeutic use*
Humans
Immunotherapy / methods*
Kidney Neoplasms / drug therapy*
Lung Neoplasms / drug therapy*
Melanoma / drug therapy*
Molecular Targeted Therapy / methods*
Substances
Cancer Vaccines
Grants and funding
P30 CA006973/CA/NCI NIH HHS/United States